MRD-positive AML Clinical Study
Clinical trial NCT07131059 · RECRUITING
Trial details
- NCT number
- NCT07131059
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-11
- Primary completion
- 2028-05-10
- Enrollment
- 537
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.